SanaGen was incorporated in 2019 and is headquartered in Amsterdam, The Netherlands. SanaGen focuses on gene therapy approaches for rare genetic disorders that can provide a life-long cure for many diseases. SanaGen is a pioneering company that focuses on transparency of costs and exploring creative ways to reduce development costs, as well as on innovative sales and contracting models for getting products to patients, and production built to serve both developed and developing countries.